Compare

Brilliance Phototherapy Device

D-Rev

last updated 5 days ago

Snapshot

Product description

A blue LED-based phototherapy device for treatment of neonatal jaundice.

Target region(s)
India, Kenya, Malawi, Myanmar, Nepal, Pakistan, Philippines, South Africa, Uganda, United Republic of Tanzania
Distributors/implementing organizations

Phoenix Medical Systems Private Ltd in Chennai India manufactures, distributes, and sells Brilliance under a license from [D-Rev] (http://d-rev.org/2010/12/brilliance-is-licensed-to-phoenix-medical/ “Brilliance Blog Post – December 22, 2010”)

Market suggested retail price

Retail $400 USD (22,000 INR) in India, [$500 USD outside of India]( http://d-rev.org/2010/12/brilliance-is-licensed-to-phoenix-medical/ “Brilliance Blog Post – December 22, 2010”)

Competitive landscape

Firefly; Medela Bilibed; Draeger Photo-Therapy; BluLine Phototherapy; Breath of Life (BOL) Phototherapy; Natus neoBLUE

SDG targeted

Goal [3] (http://www.un.org/sustainabledevelopment/sustainable-development-goals/ “http://www.un.org/sustainabledevelopment/sustainable-development-goals/”): to improve and promote good health.

Newborns with mild to severe jaundice. 1 in 6 babies require treatment for jaundice. If not treated these babies are at risk of brain damage or death.

Target user(s)

[Hospitals and clinics] (https://d-rev.s3-us-west-2.amazonaws.com/assets-old/pdf/D-Rev-Press-Release-Unprecedented-Licensing-Agreement-Dec-22-2010.pdf “https://d-rev.s3-us-west-2.amazonaws.com/assets-old/pdf/D-Rev-Press-Release-Unprecedented-Licensing-Agreement-Dec-22-2010.pdf”) with neonatal intensive care units (NICUs) or special newborn care units (SNCUs) in developing countries.

The @AutodeskFdn blogged about our how-to guide for communities writing proposals for development projects https://t.co/MlRH1H0x2F